23 Jul, 2026
According to Straits Research, the global glucose monitoring devices market size was valued at $13.88 billion in 2025 and is estimated to reach $22.64 billion by 2034, growing at a CAGR of 5.63% during the forecast period. The consistent market growth is supported by the rise in the use of implantable long-duration glucose sensors, which last up to six months, and by lowering patient burden.
The growth of the global glucose monitoring devices market is driven by the increasing prevalence of type 2 diabetes worldwide, coupled with growing awareness of the importance of effective blood glucose management. According to the International Diabetes Federation (IDF) 2025 Report, approximately 531 million people are living with type 2 diabetes, a figure projected to rise to 853 million by 2050, thereby creating sustained demand for glucose monitoring solutions. Technological advancements, such as real-time continuous glucose monitoring (CGM) systems and implantable sensors, are further enhancing patient convenience and accuracy in tracking blood sugar levels. Moreover, supportive government initiatives and reimbursement frameworks across developed regions are encouraging broader adoption of advanced monitoring devices.
However, device calibration complexities and data privacy concerns associated with digital health integration pose challenges for manufacturers and healthcare providers and restrain the glucose monitoring devices market growth. On the other hand, opportunities lie in the rapid expansion of telehealth services and remote patient monitoring programs, which are enabling broader integration of glucose monitoring devices into routine diabetes care. Moreover, increasing partnerships between medtech firms and digital health companies are strengthening device connectivity, fostering innovation, and creating a pathway toward personalized diabetes management on a global scale during the forecast period.
sales@straitsresearch.com